Grail to seek an additional $1B in funding before Hong Kong IPO, report says – FierceBiotech

FierceBiotech
Cancer blood test developer Grail is reportedly considering whether to squeeze in yet another billion-dollar funding round before it goes public in Hong Kong later this year, according to Bloomberg. The company is working to develop and validate a gene

and more

…read more

Source:: Hong Kong News By Google News

Leave a Comment